Peptid-Klartext DE Community
Medicines & co-medication

Bempedoic acid: Effects, Evidence and Risks

Also known as Nilemdo, Nustendi (with ezetimibe), Nexletol.

StatusApproved (EU)
EvidenceLarge RCTs
Drug classATP citrate lyase inhibitor (lipid-lowering) · tablet

What is Bempedoic acid?

Blocks a step of cholesterol synthesis in the liver, upstream of where statins act. Prescribed for high LDL cholesterol, especially when statins are not tolerated or not enough.

How well studied is Bempedoic acid?

Approved in the EU since April 2020. In the large outcome trial (CLEAR Outcomes, almost 14,000 statin-intolerant patients) fewer cardiovascular events occurred on bempedoic acid than on placebo (11.7% vs. 13.3%).

What side effects and risks does Bempedoic acid have?

Commonly raised uric acid and gout attacks, muscle/limb pain, anaemia. Interactions with certain statins are possible (needs medical coordination). No known direct interaction with GLP-1 drugs; extra caution with a history of gout.

Is Bempedoic acid approved in Germany?

In short: yes. Approved in Germany/EU (Nilemdo, combination Nustendi), prescription-only. Not on the WADA Prohibited List. Taking it without a prescription and medical monitoring – e.g. bought from “peptide shops” – is dangerous: unknown quality, no lab checks, no adjustment to blood pressure, kidney values or other medicines.

Sources

Note: We deliberately do not list any doses here. For approved medicines, your doctor sets the dose; for unapproved substances there is no reliable information.